Fernández-figueras, MT, Pérez-muñoz, N, Puig, L, Posada-caez, R, Victoria, RB, Henriquez, M, Musulen, E. Predictors of Local Invasion in Infiltrative Basal Cell Carcinoma: Tumour Budding Outperforms the WHO Subtyping. ACTA DERMATO-VENEREOLOGICA. 2024; 104DOI:10.2340/actadv.v104.40172. PMID:38956962. IF:3.700(Q1/2D).

Puig, L, Tsai, TF, Soriano, ER, Bhutani, T, Miller, M, Kollmeier, AP, Li, S, You, Y, Li, HW, Patel, H, Lavie, F, Gooderham, M, Londoño, A, Lebwohl, M, Nash, P. SAFETY IN PATIENTS WITH LATENT TUBERCULOSIS WHO RECEIVED CONCOMITANT ANTITUBERCULOSIS MEDICATIONS: ANALYSIS OF 11 STUDIES OF GUSELKUMAB IN PSORIATIC DISEASE. ACTA DERMATO-VENEREOLOGICA. 2024; 104DOI:. PMID:. IF:3.700(Q1/2D).

Balado-Simo, P, Morgado-Carrasco, D, Gomez-Armayones, S, Lopez-Ferrer, A, Barco, D, Ferrándiz-Pulido, C, Podlipnik, S. An Updated Review of Topical Tretinoin in Dermatology: From Acne and Photoaging to Skin Cancer. Journal of Clinical Medicine. 2025; 14(22)DOI:10.3390/jcm14227958. PMID:41302994. IF:2.900(Q1/2D).

Jiménez-Sánchez, A, Moreno-Arrones, OM, Béa-Ardebol, S, Mayo-Martínez, F, Pérez-Pastor, G, Torres-Navarro, I, Bonfill-Orti, M, Ruiz-Salas, V, Masferrer, E, Martos-Cabrera, L, Deza, G, Cabrera, RFDM, Feal, C, Turrión-Merino, L, Toll, A, Pérez, CA, Estrada, RB, Yébenes, M, Galiano-Mejías, S, Jiménez-Gallo, D, Ferrandiz-Pulido, C, Florez, A, Hernández-Hernández, N, Rios-Buceta, L, Sanmartín, O, Blanco, CC, Jaka, A, Just-Sarobé, M, Conde-Taboada, A, Arenal, MM, Vargas-Laguna, E, León, IA, Leal, L, Montalvo, SM, Polo, I, Hernández-Marín, B, Soria, A, Delgado-Jiménez, Y, Rodriguez-Jiménez, P. Response to Sonidegib in Advanced Basal Cell Carcinomas by Histological Subtype: A Real-World Cohort. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2025; 64(11)DOI:10.1111/ijd.17896. PMID:40468572. IF:3.200(Q1/3D).

Mansilla-Polo, M, García-Moronta, C, Fernández-Crehuet, P, Garbayo-Salmons, P, Pons-Benavent, M, Aguilar-González, L, Jiménez-Gallo, D, Alcalá-García, R, Martín-Ezquerra, G, Martorell, A, Mahiques-Santos, L, Alfageme-Roldán, F, Escutia-Muñoz, B, Sahuquillo-Torralba, A, Fayos-Gregori, R, Soto-Moreno, A, Sánchez-Gutiérrez, I, Botella-Estrada, R, Vilarrasa, E, Molina-Leyva, A. Long-Term Effectiveness and Safety of Bimekizumab in Patients with Moderate to Severe Hidradenitis Suppurativa Under Real Clinical Practice Conditions: The Importance of Combined Treatment in Hurley III Patients and Potential Factors Associated with Complete Response. Dermatology and Therapy. 2025; 15(11)DOI:10.1007/s13555-025-01521-z. PMID:40866757. IF:4.200(Q1/1D).

Papp, KA, Puig, L, Beecker, J, Chandran, V, Claveau, J, Cortes, J, Dutz, J, Hornick, NI, Juergens, RA, Melosky, B, Patel, AB, Sauder, MB, Sehdev, S, Sibaud, V, Snow, SL. Systemic treatment of immune checkpoint inhibitor-induced psoriasis: Inference-based guidance. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2025; 39(11)DOI:10.1111/jdv.20809. PMID:40685883. IF:8.000(Q1/1D).